1
Jongkees, M. J., Tan, N. H., Geers, D., de Vries, R. D., GeurtsvanKessel, C. H., Hensley, K. S., Sablerolles, S. G., Bogers, S., Blakaj, B., Afonso, P. Miranda, Hansen, B. E., Rijnders, B. J. A., Brinkman, K., van der Kuy, H. M., Roukens, A. H. E., Rokx, C.
Veröffentlicht in: Jongkees , M J , Tan , N H , Geers , D , de Vries , R D , GeurtsvanKessel , C H , Hensley , K S , Sablerolles , S G , Bogers , S , Blakaj , B , Afonso , P M , Hansen , B E , Rijnders , B J A , Brinkman , K , van der Kuy , H M , Roukens , A H E & Rokx , C 2024 , ' Immunogenicity of a bivalent BA.1 COVID-19 booster vaccine in people with HIV in the Netherlands ' , HIV Medicine , vol. 38 , no. 9 , pp. 1355-1365 . https://doi.org/10.1097/qad.0000000000003933;
2024
Veröffentlicht in: Jongkees , M J , Tan , N H , Geers , D , de Vries , R D , GeurtsvanKessel , C H , Hensley , K S , Sablerolles , S G , Bogers , S , Blakaj , B , Afonso , P M , Hansen , B E , Rijnders , B J A , Brinkman , K , van der Kuy , H M , Roukens , A H E & Rokx , C 2024 , ' Immunogenicity of a bivalent BA.1 COVID-19 booster vaccine in people with HIV in the Netherlands ' , HIV Medicine , vol. 38 , no. 9 , pp. 1355-1365 . https://doi.org/10.1097/qad.0000000000003933;
2024